All entries for: ODDIFACT SAS

FDA orphan drug designation: treatment of Takayasu arteritis

FDA orphan drug designation: treatment of Behcet’s disease

FDA orphan drug designation: treatment of pyoderma gangrenosum

FDA orphan drug designation: treatment of bullous pemphigoid

FDA orphan drug designation: treatment of autoimmune hemolytic anemia